Editorial: Pharmaceutical care and wellness of diabetes
Frontiers in Clinical Diabetes and Healthcare · 30.06.2026 · 7
DOI: 10.3389/fcdhc.2026.1910046 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Clinical Diabetes and Healthcare, online erschienen am 30.06.2026. Verfasst von Havagiray R Chitme und 2 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
This special issue, titled "Pharmaceutical Care and Wellness of Diabetes," was aimed to bridge the gap between traditional medicine systems and contemporary science by collating research, reviews, and meta-analyses that scientifically validate ethnomedicines having potential role in bringing wellness in diabetic care. The collection of studies in this section emphasized the integration of ancient sciences with current medical practices, in fostering the development of novel therapeutic approaches based on novel mechanism of action that might be both efficacious as well as safe.We have included a broad spectrum of studies exploring the mechanisms of action, efficacy, safety, and clinical outcomes of alternative, complementary, herbal, Ayurvedic, Chinese, native, and ethnic therapies related to diabetes management. Furthermore, the studies cover the modern innovative medical methodologies such as in silico modelling, computer-aided drug design, and highlighting the network pharmacology as pivotal tools to deepen our understanding of ethnomedicines. The following papers exemplify this integrative approach, addressing diverse aspects of diabetes care through traditional and modern scientific perspectives:The systematic review and meta-analysis of Zhang et.al. was aimed to assess the efficacy and safety of the traditional Chinese medicine Shengjiang powder in combination with conventional therapy for the treatment of diabetic kidney disease. It significantly improvised urinary protein, urinary albumin excretion rate, microalbuminuria, blood urea nitrogen, serum creatinine, fasting and 2hPG blood glucose, hemoglobin A1c, total cholesterol and triglycerides. Traditional Thai formulation was studied for wound-healing properties of a gauze dressing infused with Ya-Samarn-Phlae. The authors demonstrated that the formulation not only accelerates wound closure but also balances collagen synthesis and reduces oxidative stress, highlighting its potential as an affordable, effective alternative for diabetic wound management-particularly in resource-limited settings. Another Chinese herbal formulation Huoxue-Jiangtang decoction found to have promising results in treating type 2 diabetes mellitus through lowering fasting blood glucose levels, improved insulin sensitivity, and repair injured pancreatic islets. Molecular mechanism demonstrated that it works by activating the PI3K/AKT signaling pathway and increasing GLUT4 protein expression in skeletal muscles to facilitate glucose uptake along with reduction in lipid metabolism disorders, antioxidant and anti-inflammatory properties. This research exemplifies how integrating ethnomedicine with modern scientific methodologies can lead to novel therapeutic strategies for chronic diabetic wounds, kidney disease and inflammation. study of Niu et.al. clarifies the nephroprotective mechanisms of Trigonella foenumgraecum L. by effectively regulated glycemic index by modulatory mechanism involving PI3K-Akt-ERK signaling pathway, due to downregulation of the over-expressed mRNA and protein levels of important intracellular nodes, including MAPK1, MAPK3, AKT1, and PI3K. Beta-boswellic acid facilitates diabetic wound healing by targeting STAT3 and inhibiting ferroptosis in fibroblasts, explores the therapeutic potential of a plant-derived pentacyclic triterpene, beta-boswellic acid (β-BA), in promoting diabetic wound healing. The authors demonstrated that β-BA exerts its effects by modulating ferroptosis through the regulation of STAT3 signaling pathways. Tripterygium wilfordii its chemical constituents celastrol, triptolide and triptonide acts through TGF-β/Smad, NF-ΚB, and JAK/STAT to produce anti-inflammatory and anti-tumor activities. Wang et.al., presents comprehensive proteomics and metabolomics analyses, demonstrating extracts of Knoxia roxburghii significantly downregulated key proteins involved in glucose metabolism, oxidative stress, and pancreatic function, thereby inhibiting gluconeogenesis, reducing oxidative damage, and preserving pancreatic islet architecture. The meta-analysis by Wang et al. on the efficacy and safety of berberine, a plant-derived isoquinoline alkaloid used in many traditional system including Chinese medicine for treating type 2 diabetes mellitus. Exemplifying how modern molecular approaches can uncover the cellular targets of traditional bioactive medicinal compounds extracted from the plants, as an innovative treatment strategy for the diabetes and associated complication care.Zhou et.al., explored gut-skin axis as a pivotal factor in diabetic foot ulcer pathogenesis and healing. By elucidating mechanisms involving short-chain fatty acids, anti-inflammatory pathways, and key signaling cascades, the authors propose an integrated, multi-targeted approach for the management of DFU that further emphasizes the interconnectedness of the gut health with the skin healing. This work underscores the importance of harnessing traditional medicine within a modern scientific framework to address complex diabetic complications. Type D personality is one of the most bothering psychobehavioural disorders associated with diabetes. The study was based on cluster random sampling method, involving 1000 patients with diabetes from multiple tertiary care hospitals. It has been reported that prevalence of risk of depression and type D personality in patients with diabetes increases. It is also mentioned that the social support intervention can help in managing the mental health and reducing the risk of depression and perception of social support. Alenzi et al. described the efficacy of semaglutide in Saudi Arabian patients with type 2 diabetes mellitus over 12-month period. The mean HbA1c was significantly reduced, along with the body weight, and the lipid profiles were significantly improved. Multivariate analysis revealed that baseline HbA1C, disease duration, and insulin use were significant predictors of HbA1C change, while insulin use alone was predictive of the magnitude of weight loss. SGLT2 inhibitors were compared with DPP4 inhibitors to understand the diabetic kidney disease. In this retrospective study, SGLT2i treatment prominently reduced eGFR than DPP4i irrespective of prior rate of eGFR. However, there was no difference was observed in urinary albumin-tocreatinine ratio between groups. Rea et.al., provides a comprehensive synthesis of preclinical evidence supporting the protective effects of GLP-1 receptor agonists (GLP-1RAs) on pancreatic beta cells attracted a significant interest for their potential not only to enhance insulin secretion but also to preserve beta cell mass. The authors demonstrate that GLP-1RAs consistently reduce beta cell apoptosis; "highlighting their promise as therapeutic agents that may slow disease progression". These findings reinforce the importance of further longitudinal clinical studies to translate preclinical benefits into effective, long-lasting treatments for DM.As we reflect on the diverse and innovative research presented in this special issue, it becomes clear that the integration ethnomedicine and modern scientific approaches holds tremendous promise for advancing diabetes care. From traditional herbal formulations and natural extracts to cutting-edge molecular targeting and computational modelling, these studies exemplify a holistic and multidisciplinary effort to unlock the therapeutic potential of ancient knowledge systems. They not only deepen our understanding of the complex mechanisms underlying diabetic complications but also enable us to develop safer, more effective, and culturally acceptable treatments.The synergy between traditional wisdom and contemporary science underscores a paradigm shift towards the personalized and integrative medicine; "the approach that might be recognizing the value of ethnomedicines while rigorously validating their efficacy and safety". For instance, the researchers contributing to this special issue explored the gut-skin axis, as well as the ferroptosis regulations, and the novel use of bioactive compounds. It reveals that the future of diabetes management looks increasingly promising. We hope, these article collections will inspire further research collaborations for the clinical translational studies worldwide to develop approaches that may redefine the landscape of diabetes care, promoting wellness and happiness in the years to come, and ultimately aimed at improving the quality of life for the millions of people around the globe affected by this chronic disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India.
- Faculty of Medicine, The Chinese University of Hong Kong (CUHK), Hong Kong, Hong Kong SAR, China.
- School of Pharmaceutical Sciences, Chhatrapati Shahu Ji Maharaj University, Kanpur, India.
Zitieren
APA
Chitme, H. R., Baig, M. M. F. A., & Gupta, A. K. (2026). Editorial: Pharmaceutical care and wellness of diabetes. Frontiers in Clinical Diabetes and Healthcare, 7. https://doi.org/10.3389/fcdhc.2026.1910046
Vancouver
Chitme HR, Baig MMFA, Gupta AK. Editorial: Pharmaceutical care and wellness of diabetes. Frontiers in Clinical Diabetes and Healthcare. 2026;7. doi:10.3389/fcdhc.2026.1910046
BibTeX
@article{Chitme2026,
author = {Chitme, Havagiray R and Baig, Mirza Muhammad Faran Ashraf and Gupta, Ajay Kumar},
title = {Editorial: Pharmaceutical care and wellness of diabetes},
journal = {Frontiers in Clinical Diabetes and Healthcare},
year = {2026},
volume = {7},
doi = {10.3389/fcdhc.2026.1910046}
}
EUVIMED